PATENT CLAIM ANALYSIS

Application Number: 15769630
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["424", "450000"]

Abstract:
The present invention relates to liposomal compositions, comprising liposomes comprising tetraether lipids (TELs) and cell penetrating peptides (CPPs), wherein said CPPs are attached to a compound being part of the liposome's lipid double layer. The present invention further relates to uses thereof for the oral delivery of therapeutic and/or diagnostic agents.

Claim (Index 6):
The liposomal composition according to  claim 1 , wherein said CPPs are selected from the group consisting of linear or cyclized penetratin (SEQ ID NO: 1), TAT (transactivator of transcription)-peptide (SEQ ID NO: 2), MAP (model amphiphatic peptide) (SEQ ID NO: 3), R9 (SEQ ID NO: 4), pVEC (SEQ ID NO: 5), transportan (SEQ ID NO: 6), and MPG (SEQ ID NO: 7), combinations thereof, and dimers thereof.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 91.0
- Lexical Diversity: 1.30435
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14492060', '13816461', '15221832', '15503010', '14211957']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7509093399572339
- 35 USC 102 Novelty (BERT): 0.4774163617923326
- Combined Prediction Score: 0.7235600421407438
- Mean Citation Score: 193.480214
- Max Citation Score: 199.96426
- Similarity Product: 155.56239645537852

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test